Poornima Saha

NorthShore University HealthSystem — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

6h-index282citations30works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(9), Estrogen and related hormone effects(8), Cancer Treatment and Pharmacology(7), HER2/EGFR in Cancer Research(6), Ovarian cancer diagnosis and treatment(4)

Publications30 total

Abstract PS4-11-21: Breast Cancer Trends and Outcomes Among Young Hispanic and Asian/Pacific Islander Women Age < 40 in the National Cancer Database (NCDB) adjusted for U.S. population data
Clinical Cancer Research·2026
Adjuvant Chemotherapy Use for Hormone Receptor–Positive, <i>ERBB2</i> -Negative Breast Cancer After RxPONDER Trial
JAMA Network Open·2025· 2 citedOpen Access
Abstract C067: Race and age-related differences in adjuvant chemotherapy use for hormone receptor-positive/HER2-negative breast cancer by genomic risk
Cancer Epidemiology Biomarkers & Prevention·2025
Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer
Breast Cancer Research and Treatment·2025Open Access
Abstract PS11-06: Leveraging AI to Predict Recurrence-Free Survival in Breast Cancer Patients through Image-Based assessment of Tumor Characteristics
Clinical Cancer Research·2025
Abstract P2-08-10: Real World Use of Ovarian Function Suppression in Women Younger Than 35 with Early Stage ER+Her2- Breast Cancer
Clinical Cancer Research·2025
Abstract P2-05-02: IDENTIFICATION OF MOST COMMON CONCERNS IN BREAST CANCER SURVIVORS FROM 2019-2023 IN THE MRW LIFE SURVIVORSHIP PROGRAM
Clinical Cancer Research·2025
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer
Breast Cancer Research and Treatment·2025· 2 citedOpen Access
High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration
Breast Cancer Research and Treatment·2024· 3 citedOpen Access
Updates in Breast Cancer Screening and Diagnosis
Current Treatment Options in Oncology·2024· 8 cited
A Randomized Phase II Trial of Nab-paclitaxel with or without Mifepristone for Advanced Triple-Negative Breast Cancer
2024· 1 citedOpen Access
Use of cardiac biomarkers to improve initiation of cardioprotective therapy in patients with breast cancer receiving cardiotoxic chemotherapy in a multidisciplinary cancer center.
JCO Oncology Practice·2024· 1 cited
Development and validation of a clinical breast cancer tool for accurate prediction of recurrence
npj Breast Cancer·2024· 10 citedOpen Access
Abstract PO1-01-11: Development and Validation of a Breast Cancer Recurrence Model Demonstrates Accurate Identification of Patients with Favorable Long-Term Outcomes
Cancer Research·2024
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.
Journal of Clinical Oncology·2023· 3 cited
Phase II study of pembrolizumab plus mifepristone in patients with advanced HER2-negative breast cancer.
Journal of Clinical Oncology·2023· 1 cited
Abstract P3-05-02: Trends in clinical treatment of early stage ER+PR- breast cancer in the National Cancer Database
Cancer Research·2023
Abstract P6-01-36: Validation of prognostic platform to further refine identification High Risk Patients indicated for Chemotherapy Free Treatment in Early-Stage Breast Cancer
Cancer Research·2023
Abstract P5-03-15: Application of 21-gene Breast Recurrence Score® assay to evaluate prognosis and benefit of adjuvant chemotherapy in BRCA1 and BRCA2 pathogenic variant carriers with early stage, estrogen receptor positive breast cancer
Cancer Research·2023· 1 cited
Improving cardiac monitoring in patients with early-stage breast cancer receiving cardiotoxic chemotherapy in a multidisciplinary cancer center.
Journal of Clinical Oncology·2022· 2 cited
page 1 of 2Next →

Frequent Co-authors

Rita Nanda(11), Gini F. Fleming(9), Suzanne D. Conzen(9), Frederick M. Howard(9), Jincong Q. Freeman(7), Erica Stringer-Reasor(6), Olwen Hahn(6), Theodore Karrison(6), Megan Sullivan(4), Katharine Yao(4), Murtuza Rampurwala(4), Margarite D. Matossian(4), Masha Kocherginsky(3), Philip C. Hoffman(3), Kyla Lee(3), Sailaja Kamaraju(3), Gabrielle M. Baker(3), Kristine Kuchta(3), Asim Dhungana(2), Augustin Vannier(2)